Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Mustea

Showing results (81-90 of 172) with videos related to

Pageof 18
Sort By:
Gynecologic Oncology|February 10, 2007
Vascular endothelial growth factor gene polymorphisms in ovarian cancerStephan Polterauer, Christoph Grimm, Alexander Mustea, et al.
Life Sciences|March 13, 2021
Gene expression in the Angiopoietin/TIE axis is altered in peripheral tissue of ovarian cancer patients: A prospective observational studyAlexander Kinnen, Sven Klaschik, Claudia Neumann, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 18, 2009
Development of the Berlin Symptom Checklist Ovary (BSCL-O) for the measurement of quality of life of patients with primary and recurrent ovarian cancer: results of a phase I and II studyDominique Koensgen, Guelten Oskay-Oezcelik, Ioanna Katsares, et al.
Anticancer Research|July 5, 2020
Determination of Immediate <i>vs.</i> Kinetic Growth Retardation in Physically Plasma-treated Cells by Experimental and Modelling DataLyubomir Haralambiev, Arnab Bandyophadyay, Bettina Suchy, et al.
Anticancer Research|December 30, 2025
Paucimannosylation Is a Prognostic Marker in High-grade Serous Ovarian CancerEva Egger, Sarah Förster, Lina Adloff, et al.
Anticancer Research|June 29, 2007
Epidermal growth factor receptor (EGFR) mutation does not correlate with platinum resistance in ovarian carcinoma. Results of a prospective pilot studyAlexander Mustea, Jalid Sehouli, Gerhild Fabjani, et al.
Anticancer Research|December 1, 2017
Cold Atmospheric Plasma (CAP) and CAP-Stimulated Cell Culture Media Suppress Ovarian Cancer Cell Growth - A Putative Treatment Option in Ovarian Cancer TherapyDominique Koensgen, Ilma Besic, Denis Gümbel, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 20, 2022
Lipid reprogramming induced by the TFEB-ERRα axis enhanced membrane fluidity to promote EC progressionXiaodan Mao, Huifang Lei, Tianjin Yi, et al.
Cancers|January 21, 2023
Pleiotropic Devitalization of Renal Cancer Cells by Non-Invasive Physical Plasma: Characterization of Molecular and Cellular EfficacyAndreas Nitsch, Caroline Sander, Benedikt Eggers, et al.
International Journal of Molecular Sciences|September 30, 2020
Inhibition of Angiogenesis by Treatment with Cold Atmospheric Plasma as a Promising Therapeutic Approach in OncologyLyubomir Haralambiev, Ole Neuffer, Andreas Nitsch, et al.
Pageof 18

Showing results (81-90 of 172) with videos related to

Sort By:
Pageof 18
Gynecologic Oncology|February 10, 2007
Vascular endothelial growth factor gene polymorphisms in ovarian cancerStephan Polterauer, Christoph Grimm, Alexander Mustea, et al.
Life Sciences|March 13, 2021
Gene expression in the Angiopoietin/TIE axis is altered in peripheral tissue of ovarian cancer patients: A prospective observational studyAlexander Kinnen, Sven Klaschik, Claudia Neumann, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 18, 2009
Development of the Berlin Symptom Checklist Ovary (BSCL-O) for the measurement of quality of life of patients with primary and recurrent ovarian cancer: results of a phase I and II studyDominique Koensgen, Guelten Oskay-Oezcelik, Ioanna Katsares, et al.
Anticancer Research|July 5, 2020
Determination of Immediate <i>vs.</i> Kinetic Growth Retardation in Physically Plasma-treated Cells by Experimental and Modelling DataLyubomir Haralambiev, Arnab Bandyophadyay, Bettina Suchy, et al.
Anticancer Research|December 30, 2025
Paucimannosylation Is a Prognostic Marker in High-grade Serous Ovarian CancerEva Egger, Sarah Förster, Lina Adloff, et al.
Anticancer Research|June 29, 2007
Epidermal growth factor receptor (EGFR) mutation does not correlate with platinum resistance in ovarian carcinoma. Results of a prospective pilot studyAlexander Mustea, Jalid Sehouli, Gerhild Fabjani, et al.
Anticancer Research|December 1, 2017
Cold Atmospheric Plasma (CAP) and CAP-Stimulated Cell Culture Media Suppress Ovarian Cancer Cell Growth - A Putative Treatment Option in Ovarian Cancer TherapyDominique Koensgen, Ilma Besic, Denis Gümbel, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 20, 2022
Lipid reprogramming induced by the TFEB-ERRα axis enhanced membrane fluidity to promote EC progressionXiaodan Mao, Huifang Lei, Tianjin Yi, et al.
Cancers|January 21, 2023
Pleiotropic Devitalization of Renal Cancer Cells by Non-Invasive Physical Plasma: Characterization of Molecular and Cellular EfficacyAndreas Nitsch, Caroline Sander, Benedikt Eggers, et al.
International Journal of Molecular Sciences|September 30, 2020
Inhibition of Angiogenesis by Treatment with Cold Atmospheric Plasma as a Promising Therapeutic Approach in OncologyLyubomir Haralambiev, Ole Neuffer, Andreas Nitsch, et al.
Pageof 18